|
HY-N2558-1mg
|
MedChemexpress LLC
|
Mu rrayone [CAS 19668-69-0]
|
|
Cancer-programmed cell death
|
|
|
HY-N2558-10mg
|
MedChemexpress LLC
|
Mu rrayone [CAS 19668-69-0]
|
|
Cancer-programmed cell death
|
|
|
HY-N2558-5mg
|
MedChemexpress LLC
|
Mu rrayone [CAS 19668-69-0]
|
|
Cancer-programmed cell death
|
|
|
HY-111646-10mg
|
MedChemexpress LLC
|
N6-Etheno 2'-deoxyadenosine [CAS 68498-25-9]
|
|
COVID-19-anti-virus
|
|
|
HY-111646-5mg
|
MedChemexpress LLC
|
N6-Etheno 2'-deoxyadenosine [CAS 68498-25-9]
|
|
COVID-19-anti-virus
|
|
|
HY-D1117-1mg
|
MedChemexpress LLC
|
NADA-green [CAS 2253733-11-6]
|
|
|
|
|
HY-F0003-100mg
|
MedChemexpress LLC
|
NADPH (tetrasodium salt) [CAS 2646-71-1]
|
|
Cancer-programmed cell death
|
|
|
HY-F0003-50mg
|
MedChemexpress LLC
|
NADPH (tetrasodium salt) [CAS 2646-71-1]
|
|
Cancer-programmed cell death
|
|
|
HY-F0003-1mL
|
MedChemexpress LLC
|
NADPH (tetrasodium salt) [CAS 2646-71-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-136409-10mg
|
MedChemexpress LLC
|
N-Decanoyl-L-homoserine lactone [CAS 177315-87-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-136409-100mg
|
MedChemexpress LLC
|
N-Decanoyl-L-homoserine lactone [CAS 177315-87-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-136409-25mg
|
MedChemexpress LLC
|
N-Decanoyl-L-homoserine lactone [CAS 177315-87-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-136409-5mg
|
MedChemexpress LLC
|
N-Decanoyl-L-homoserine lactone [CAS 177315-87-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-136409-50mg
|
MedChemexpress LLC
|
N-Decanoyl-L-homoserine lactone [CAS 177315-87-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-14956-1mg
|
MedChemexpress LLC
|
Nemonoxacin [CAS 378746-64-6]
|
|
|
|
|
HY-14956-10mg
|
MedChemexpress LLC
|
Nemonoxacin [CAS 378746-64-6]
|
|
|
|
|
HY-14956-5mg
|
MedChemexpress LLC
|
Nemonoxacin [CAS 378746-64-6]
|
|
|
|
|
HY-14956S-1mg
|
MedChemexpress LLC
|
Nemonoxacin-d3
|
|
COVID-19-immunoregulation
|
|
|
HY-14956S-5mg
|
MedChemexpress LLC
|
Nemonoxacin-d3
|
|
COVID-19-immunoregulation
|
|
|
HY-P1607-1g
|
MedChemexpress LLC
|
Nisin [CAS 1414-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1607-100mg
|
MedChemexpress LLC
|
Nisin [CAS 1414-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1607-5g
|
MedChemexpress LLC
|
Nisin [CAS 1414-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1607-500mg
|
MedChemexpress LLC
|
Nisin [CAS 1414-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P701027-100ug
|
MedChemexpress LLC
|
NLRP3, Human (GST)
|
|
|
|
|
HY-P701027-20ug
|
MedChemexpress LLC
|
NLRP3, Human (GST)
|
|
|
|
